seekingalpha.com /4 weeks ago

Gentex Corporation (GNTX) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Gentex Q3 2026 Earnings Preview

Read source
qchron.com /4 weeks ago

Gentex Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Gentex (GNTX)

Gentex lowered its 2026 revenue guidance to approximately $2.65 billion, down from a prior range of $2.65 billion to $2.75 billion. Shareholders holding losses may have rights wort...

Read source
investing.com /4 weeks ago

Earnings call transcript: Gentex misses Q3 2026 estimates, shares fall 6.8%

Read source
fool.com /3 weeks ago

Glaukos (GKOS) Q3 2026 Earnings Call Transcript

Record sales and margin expansion driven by iDose TR and Epioxa launches.

Read source
seekingalpha.com /1 month ago

Glaukos: Steep Premium For New Therapies And Growth

Read source
investing.com /1 month ago

SpyGlass Pharma reports 4-year glaucoma implant trial results

Read source
seekingalpha.com /1 month ago

Opus Genetics, Inc. (IRD) Presents at Euretina 2026 - Slideshow

Read source
investing.com /1 month ago

MeiraGTx chief scientific officer Naylor sells $294,291 in shares

Read source
fool.com /1 month ago

Meet the Super Semiconductor Stock Crushing Nvidia in 2026

This 175-year-old glassmaker is now at the center of the artificial intelligence boom.

Read source
seekingalpha.com /1 month ago

NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation...

Read source
seekingalpha.com /1 month ago

GNT And GNT.PR.A: Balancing Yield, Security, And Interest Rate Risk

Read source
seekingalpha.com /4 weeks ago

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

Annexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy - Slideshow

Read source
seekingalpha.com /1 month ago

Alcon wins approval of OTC Brytly eye drops

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreeme...

Read source
orthospinenews.com /5 days ago

NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates

MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) — NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative…

Read source
seekingalpha.com /1 week ago

Cognex Corporation 2026 Q3 - Results - Earnings Call Presentation

Read source
seekingalpha.com /2 weeks ago

Nuvectis Pharma, Inc. (NVCT) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

TNL Mediagene regains Nasdaq minimum bid price compliance

Read source
seekingalpha.com /3 weeks ago

PT GoTo Gojek Tokopedia Tbk (GTOFF) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 week ago

Nkarta, Inc. (NKTX) Discusses Initial NKX019 Clinical Data in Myositis and Systemic Sclerosis - Slideshow

Read source
seekingalpha.com /1 month ago

Vuzix: Promising IP Within Data Centers And Industrial Settings, But Too Risky

Read source
investmentwatchblog.com /1 month ago

ER-100 – aging reversal drug first test results in the EYE with Glaucoma announced

Safety phase. 2 of 3 patients given LOW DOSES reported vision improvement. Phase 2 – Doses will now triple in size for next round. Today, at the American Academy of Ophthalmology A...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.